Fever News and Research

RSS

Griffith University's Institute for Glycomics launches human trials for Streptococcus A vaccine

Griffith University's Institute for Glycomics has launched human trials for a vaccine against Streptococcus A, the germ that causes rheumatic fever.

1 Mar 2013

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

NanoViricides, Inc., announced today that it has retired the remainder of the Series C Convertible Preferred Stock previously purchased by Seaside 88, LP, with a cash payment.

27 Feb 2013

Inviragen to initiate second stage of DENVax Phase 2 study in dengue

Inviragen, Inc. today announced the initiation of the second stage of an ongoing Phase 2, randomized, double-blind, placebo-controlled study of DENVax, the Company's investigational dengue vaccine.

27 Feb 2013

Viewpoints: Former Sen. Gramm criticizes Obama on budget cuts; Debate on revamping Medicare needs less heat, more deliberation

While history shows that a divided government can enact significant spending cuts as an alternative to sequesters, that doesn't appear to be the path Mr. Obama intends to follow. Instead of protecting civilian defense workers, the president will continue to force the Pentagon to buy biofuels at $27 per gallon to promote his green agenda.

27 Feb 2013

‘Traffic light’ guide for pediatric bacterial infection needs refining

Study results suggest that a “traffic light” system for categorizing the severity of infections in children fails to detect a substantial number of serious bacterial infections, particularly urinary tract infections.

26 Feb 2013

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.

26 Feb 2013

Loyola offers tips to avoid sledding injuries in kids

A hearty snowfall brings anticipation for one of winter's highlights - sledding. The adrenaline from speeding down an icy hill, feeling the snow spraying your face and the wind's icy fingers nearly taking your breath away can be exhilarating. There is nothing like tearing down a perfect sledding hill to get rid of cabin fever. However, serious injuries can accompany the winter fun if precautions are not taken.

21 Feb 2013

NIAID-funded Phase I trial to evaluate two related candidate vaccines against shigellosis

Researchers have launched an early-stage human clinical trial of two related candidate vaccines to prevent infection with Shigella, bacteria that are a significant cause of diarrheal illness, particularly among children.

21 Feb 2013

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

UCB announced today two new regulatory filings with the US Food and Drug Administration (FDA) and with the European Medicines Agency (EMA) to extend the marketing authorization for Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis (PsA) and for adult patients with active axial spondyloarthritis (axSpA).

20 Feb 2013

Immunotherapy could be answer to treating novel coronavirus

Investigation into the mechanism of action of the novelcoronavirus HCoV-EMC, which recently emerged in the Middle East, has revealed that although human bronchial epithelia are very susceptible to infection with the virus, interferon I and III were both able to significantly reduce its replication in cell culture.

20 Feb 2013

BioCryst fourth quarter revenues decrease to $4.1 million

BioCryst Pharmaceuticals, Inc. announced financial results for the fourth quarter and full year ended December 31, 2012.

19 Feb 2013

General practitioners ‘may miss UTI in children’

Family doctors need to lower their threshold of suspicion for urinary tract infection in children, according to UK research.

18 Feb 2013

Study identifies regions of genes linked to Beh-et's disease

Researchers don't know the exact cause of Beh-et's disease, a chronic condition that leads to oral and genital sores and serious complications such as blindness, but new research brings better understanding to what makes some people more susceptible to being affected.

16 Feb 2013

FDA approves Novartis’ Zortress to prevent organ rejection after liver transplantation in adults

Novartis announced today that the US Food and Drug Administration (FDA) has approved Zortress (everolimus) for the prophylaxis of organ rejection in adult patients receiving a liver transplant.

16 Feb 2013

Positive new data from Genzyme’s eliglustat tartrate Phase 3 studies on Gaucher disease type 1

Genzyme, a Sanofi company, today announced positive new data from the Phase 3 ENGAGE and ENCORE studies of eliglustat tartrate, its investigational oral therapy for Gaucher disease type 1.

15 Feb 2013

Gedunin could help kill cancer cells

Scientists at the Georgia Regents University Cancer Center have identified an Indian plant, used for centuries to treat inflammation, fever and malaria, that could help kill cancer cells.

15 Feb 2013

VNI cures both acute and chronic forms of Chagas disease

Chagas disease, a deadly tropical infection caused by the protozoan parasite Trypanosoma cruzi and transmitted by biting insects called "kissing bugs," has begun to spread around the world, including the U.S. Yet current treatment is toxic and limited to the acute stage.

15 Feb 2013

Santarus launches UCERIS for induction of remission in patients with ulcerative colitis

Santarus, Inc. announced today the U.S. commercial launch of UCERIS (budesonide) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis.

14 Feb 2013

Tips for safe displays of affection during Valentine's Day

Say "I love you" with flowers, chocolates or a greeting card, but be careful when you kiss this Valentine's Day.

13 Feb 2013

Researchers describe novel antiviral property of cholesterol-25-hydroxylase

A team of UCLA-led researchers has identified a protein with broad virus-fighting properties that potentially could be used as a weapon against deadly human pathogenic viruses such as HIV, Ebola, Rift Valley Fever, Nipah and others designated "priority pathogens" for national biosecurity purposes by the National Institute of Allergy and Infectious Disease.

13 Feb 2013

Fever News and Research

Griffith University's Institute for Glycomics launches human trials for Streptococcus A vaccine

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

Inviragen to initiate second stage of DENVax Phase 2 study in dengue

Viewpoints: Former Sen. Gramm criticizes Obama on budget cuts; Debate on revamping Medicare needs less heat, more deliberation

‘Traffic light’ guide for pediatric bacterial infection needs refining

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

Loyola offers tips to avoid sledding injuries in kids

NIAID-funded Phase I trial to evaluate two related candidate vaccines against shigellosis

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

Immunotherapy could be answer to treating novel coronavirus

BioCryst fourth quarter revenues decrease to $4.1 million

General practitioners ‘may miss UTI in children’

Study identifies regions of genes linked to Beh-et's disease

FDA approves Novartis’ Zortress to prevent organ rejection after liver transplantation in adults

Positive new data from Genzyme’s eliglustat tartrate Phase 3 studies on Gaucher disease type 1

Gedunin could help kill cancer cells

VNI cures both acute and chronic forms of Chagas disease

Santarus launches UCERIS for induction of remission in patients with ulcerative colitis

Tips for safe displays of affection during Valentine's Day

Researchers describe novel antiviral property of cholesterol-25-hydroxylase

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News